Our life sciences specialists have an in-depth understanding of the corporate, commercial, intellectual property and employment issues affecting this sector.
The cross-firm team provides the range of legal services required by clients across the industry spectrum, from biotechnology, pharmaceuticals and medical devices companies to institutions or organisations that are involved in the research, development and sale of medicines, medical devices or nutritional products.
We advise on all aspects of UK and international acquisitions, disposals, joint ventures, developments and other transactions undertaken by clients, including structuring and financing, and have experience of public market fundraisings for many life science businesses.
Our expertise extends to all related areas of commercial activity, with the team advising on product licensing, manufacturing and distribution agreements, as well as IP protection and commercialisation.
The employment team at Fladgate LLP “saw substantial growth in 2015 with the recruitment of Michael McCartney … The team recently advised Alliance Pharma on the employment elements of its acquisition of 27 products from Sinclair Pharma.”
Fladgate LLP’s “approach is pragmatic and constructive”, with its “very knowledgeable lawyers providing excellent service”.
Nigel Gordon is “a capital markets lawyer with a great deal of experience advising AIM and TSX-listed clients on finance and M&A activity”.
Chris Chrysanthou is “praised for being practical and outcome-focused”.
Fladgate LLP advises on a broad variety of contracts… A “high level of service and quality” is provided by the eight-partner [commercial] team, led by Eddie Powell.
Michael McCartney led advice to Alliance Pharma on the employment aspects of its acquisition of Macuvision.
International-flavoured practice handling a wide range of transactions… “Excellent and client-driven with senior partners leading from the front in the management and delivery of transaction advice.”